Clinical Trial Update: Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a delayed-release pancrelipase in pancreatic exocrine insufficiency due to cystic fibrosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Exocrine Insufficiency

Drugs mentioned

• Pancrelipase, delayed-release (pancrelipase)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Cystic Fibrosis, Pancreatic Exocrine Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2010-03-10